Bull
$12.75
Scenario price
$15.140
-0.447 (-2.95%)At close
Sonos, Inc., and its wholly owned subsidiaries designs, develops, manufactures, and sells audio products and services. It offers customers a proprietary software platform, and the ability to stream content from a variety of sources over the customer’s wireless network or over Bluetooth. Its product lineup includes wireless, portable, and home theater speakers, headphones, components, and accessories. Its products are sold through third-party physical retailers, including custom installers of home audio systems, e-commerce retailers, and its Website sonos.com. Its products include Era 100, Era 300, Five, Roam 2, Move 2, Ray, Beam (Gen 2), Arc, Sub Mini, and Sub (Gen 3). Its proprietary software includes multi-room, multi-service experience, open platform for content partners, and smart audio tuning. Its products are distributed in more than 60 countries through retailer's physical stores and their websites, online retailers, custom installers who bundle its products with their services.
Sonos Inc is currently a hold. The stock is priced at $15.30, with a recent RSI of 42.91 indicating it is nearing oversold territory, but the forward P/E of 37.31 suggests that the stock may be overvalued based on future earnings expectations. The company reported a strong Q3 with a net income of $30 million, but the stock price dropped 18% following the earnings report, reflecting market skepticism. Additionally, the anticipated $35 million headwind to gross profit in Q4 poses a risk to short-term performance.
Morgan Stanley
$18
2026-02-04
Morgan Stanley
2026-02-04
Price Target
$18
Jefferies
$21
2026-01-05
Jefferies
2026-01-05
Price Target
$21
Morgan Stanley
$17
2025-11-06
Morgan Stanley
2025-11-06
Price Target
$17
Jefferies
$13
2025-04-07
Jefferies
2025-04-07
Price Target
$13
Rosenblatt
$18
2025-02-07
Rosenblatt
2025-02-07
Price Target
$18
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Sonos Launches Beam Ultra and Ace Ultra Headphones

Sonos CFO Sells Shares to Cover Tax Liabilities

Sonos CFO Sells Shares to Meet Tax Obligations

Sonos Shares Rebound Following Q3 Earnings Report

Sonos Reports Strong Q3 Earnings but Shares Plunge 18%
Sonos, Inc., and its wholly owned subsidiaries designs, develops, manufactures, and sells audio products and services. It offers customers a proprietary software platform, and the ability to stream content from a variety of sources over the customer’s wireless network or over Bluetooth. Its product lineup includes wireless, portable, and home theater speakers, headphones, components, and accessories. Its products are sold through third-party physical retailers, including custom installers of home audio systems, e-commerce retailers, and its Website sonos.com. Its products include Era 100, Era 300, Five, Roam 2, Move 2, Ray, Beam (Gen 2), Arc, Sub Mini, and Sub (Gen 3). Its proprietary software includes multi-room, multi-service experience, open platform for content partners, and smart audio tuning. Its products are distributed in more than 60 countries through retailer's physical stores and their websites, online retailers, custom installers who bundle its products with their services. It operates in the Technology sector (HOUSEHOLD AUDIO & VIDEO EQUIPMENT industry).
Sonos Inc is currently a hold. The stock is priced at $15.30, with a recent RSI of 42.91 indicating it is nearing oversold territory, but the forward P/E of 37.31 suggests that the stock may be overvalued based on future earnings expectations. The company reported a strong Q3 with a net income of $30 million, but the stock price dropped 18% following the earnings report, reflecting market skepticism. Additionally, the anticipated $35 million headwind to gross profit in Q4 poses a risk to short-term performance.
6 analysts cover SONO: 3 rate it Buy, 3 Hold and 0 Sell. The average price target is 19.67.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.